Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-24

Clinical Trial Update: Effect of Ketamine Intranasal Spray in Treatment of Chronic Cluster Headache [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 clinical trial evaluating intranasal ketamine for chronic cluster headache.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine intranasal spray (ketamine)

Snippet

Sponsor: CCH Pharmaceuticals | Conditions: Cluster Headache | Phase 1, Phase 2 | Status: COMPLETED